Dr. Assi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
535 Barnhill Dr
Indianapolis, IN 46202Phone+1 812-353-5536
Education & Training
- Lebanese University School of MedicineClass of 2010
Certifications & Licensure
- IN State Medical License 2022 - 2025
Publications & Presentations
PubMed
- 11 citationsLeptomeningeal metastasis as initial manifestation of signet ring colorectal adenocarcinoma: a case report with review of literature.Rita Assi, Lana Hamieh, Deborah Mukherji, Ali Haydar, Sally Temraz
Journal of Gastrointestinal Oncology. 2015-08-09 - 70 citationsFinal results of a phase 2, open‐label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high‐risk myel...Rita Assi, Hagop M. Kantarjian, Tapan M. Kadia, Naveen Pemmaraju, Elias Jabbour
Cancer. 2018-07-01 - 34 citationsAcute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.Daniel A Pollyea, Jessica K Altman, Rita Assi, Dale Bixby, Amir T Fathi
Journal of the National Comprehensive Cancer Network. 2023-05-01
Abstracts/Posters
- Sequencing of Circulating Cell-Free DNA in Patients with AML Detects Clinically Significant Mutations Not Detected in Bone Marrow: The Role for Complementary Periphera...Rita Assi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Final Results of Phase I/II Study of Selinexor (SEL) with Sorafenib in Patients (pts) with Relapsed and/or Refractory (R/R) FLT3 Mutated Acute Myeloid Leukemia (AML)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Impact of Clonal Hematopoiesis of Indeterminate Potential (CHIP) Associated Mutations and Risk of Comorbidities in Patients with Myelodysplastic Syndrome2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Diverse Landscape of TET2 Variants in MDS and AML2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: